1. PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease
   Siqi Li et al, 2022, International Immunopharmacology CrossRef
2. Novel TAK1 inhibitor handelin inhibits NF-kB and AP-1 to alleviate elastase-induced emphysema in mice
   Hye Jeong Yun et al, 2023, Life Sciences CrossRef
3. Diabetic endothelial microangiopathy and pulmonary dysfunction
   Lanlan Zhang et al, 2023, Front. Endocrinol. CrossRef
4. Prevalence and clinical characteristics of sleep disorders in chronic obstructive pulmonary disease: A systematic review and meta-analysis
   Dongru Du et al, 2023, Sleep Medicine CrossRef
5. Melatonin and mesenchymal stem cells co-administration alleviates chronic obstructive pulmonary disease via modulation of angiogenesis at the vascular-alveolar unit
   Mira Hanna et al, 2024, Pflugers Arch - Eur J Physiol CrossRef
6. Exploring TNFR1: from discovery to targeted therapy development
   Yingying Li et al, 2025, J Transl Med CrossRef